Year 2018 / Volume 25 / Number 5

Caso Clínico

Hyponatremia severe as a result of the association of a thiazide diuretic in a patient with long-term therapy with oxcarbazepine.

Rev. Soc. Esp. Dolor. 2018; 25(5): 301-302 / DOI: 10.20986/resed.2017.3527/2016

Tamara Rivero Salvador, Clara Marín Zaldivar, Pablo Baltanas Rubio, Raquel Murillo Pina, María del Pilar Aguelo Asensio, Beatriz Ruiz Torres, Marta Pedraz Natalias


ABSTRACT

Oxcarbazepine acts primarily trough its active metabolite MHD, with a lower potencial for side effects than carbamazepine. However, presents higher incidence of hyponatremia (2,7%), dosis dependent.



RESUMEN

La oxcarbazepina actúa principalmente a través de su metabolito activo MHD, por lo que presenta menor número de efectos secundarios que la carbamazepina. Sin embargo, presenta mayor tendencia a la hiponatremia (2,7 %), dosis dependiente.


New comment

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comments

No comments in this article

Related articles

Medical cannabis treatment in patients with visceral chronic pain

Rev. Soc. Esp. Dolor. 2022; 29(13): 32-42 / DOI: 10.20986/resed.2022.4030/2022

Cannabinoids in neuropathic pain: lights and shadows

Rev. Soc. Esp. Dolor. 2022; 29(13): 20-26 / DOI: 10.20986/resed.2022.4027/2022

Use of 8 % capsaicin patches for the treatment of lumbar neuropathic pain

Rev. Soc. Esp. Dolor. 2022; 29(1): 28-33 / DOI: 10.20986/resed.2022.3995/2022

Genicular nerve radiofrequency in osteoarthritis-related chronic knee pain

Rev. Soc. Esp. Dolor. 2021; 28(3): 154-168 / DOI: 10.20986/resed.2021.3900/2021

Infiltrations of steroids and hyaluronic acid in osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 64-72 / DOI: 10.20986/resed.2021.3854/2020

Clinical pathophysiology in patients with sickle cell disease: the transition from acute to chronic pain

Rev. Soc. Esp. Dolor. 2020; 27(4): 257-268 / DOI: 10.20986/resed.2020.3814/2020

New strategies for postoperative pain control in tonsillectomy surgery. Is all that glitters gold?

Rev. Soc. Esp. Dolor. 2019; 26(5): 270-275 / DOI: 10.20986/resed.2019.3742/2019

Fast opioid detoxification

Rev. Soc. Esp. Dolor. 2019; 26(2): 95-102 / DOI: 10.20986/resed.2019.3681/2018

Dysphonia as side-effect dose-dependent during treatment with duloxetine

Rev. Soc. Esp. Dolor. 2018; 25(6): 359-359 / DOI: 10.20986/resed.2017.3528/2016

Opinaudit study: clinical uses in breakthrough pain, is scientific evidence being followed up?

Rev. Soc. Esp. Dolor. 2018; 25(6): 325-334 / DOI: 10.20986/resed.2018.3634/2017

Use of major opioids for control of pain in hospitalized patients

Rev. Soc. Esp. Dolor. 2018; 25(6): 318-324 / DOI: 10.20986/resed.2018.3629/2017

Farmacologic adyuvants with saving effect of opioids in the perioperative period

Rev. Soc. Esp. Dolor. 2018; 25(5): 278-290 / DOI: 10.20986/resed.2018.3663/2018

Epidural analgesia vs. surgical wound analgesia to control acute post-operative pain in open colon surgery

Rev Soc Esp Dolor 2017; 24(5): 234-240 / DOI: 10.20986/resed.2017.3559/2016

Citation tools

Rivero Salvador T, Marín Zaldivar C, Baltanas Rubio P, Murillo Pina R, Aguelo Asensio M, Ruiz Torres B, et all. Hyponatremia severe as a result of the association of a thiazide diuretic in a patient with long-term therapy with oxcarbazepine.. Rev Soc Esp Dolor 2018; 25(5): 301-302 / DOI: 1020986/resed20173527/2016


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics

This article has received 24136 visits.
This article has been downloaded 3 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 29/10/2016

Accepted: 31/10/2016

Online First: 04/01/2017

Published: 03/10/2018

Article Online First time: 67 days

Article editing time: 704 days


Share

This article hasn't been rated yet.
Reader rating:
Rate this article:
© 2025 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

      Indexed in: